Literature DB >> 19433702

A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial.

Ulrika Gillespie1, Anna Alassaad, Dan Henrohn, Hans Garmo, Margareta Hammarlund-Udenaes, Henrik Toss, Asa Kettis-Lindblad, Håkan Melhus, Claes Mörlin.   

Abstract

BACKGROUND: Patients 80 years or older are underrepresented in scientific studies. The objective of this study was to investigate the effectiveness of interventions performed by ward-based pharmacists in reducing morbidity and use of hospital care among older patients.
METHODS: A randomized controlled study of patients 80 years or older was conducted at the University Hospital of Uppsala, Uppsala, Sweden. Four hundred patients were recruited consecutively between October 1, 2005, and June 30, 2006, and were randomized to control (n = 201) and intervention (n = 199) groups. The interventions were performed by ward-based pharmacists. The control group received standard care without direct involvement of pharmacists at the ward level. The primary outcome measure was the frequency of hospital visits (emergency department and readmissions [total and drug-related]) during the 12-month follow-up period.
RESULTS: Three hundred sixty-eight patients (182 in the intervention group and 186 in the control group) were analyzed. For the intervention group, there was a 16% reduction in all visits to the hospital (quotient, 1.88 vs 2.24; estimate, 0.84; 95% confidence interval [CI], 0.72-0.99) and a 47% reduction in visits to the emergency department (quotient, 0.35 vs 0.66; estimate, 0.53; 95% CI, 0.37-0.75). Drug-related readmissions were reduced by 80% (quotient, 0.06 vs 0.32; estimate, 0.20; 95% CI, 0.10-0.41). After inclusion of the intervention costs, the total cost per patient in the intervention group was $230 lower than that in the control group.
CONCLUSION: If implemented on a population basis, the addition of pharmacists to health care teams would lead to major reductions in morbidity and health care costs.

Entities:  

Mesh:

Year:  2009        PMID: 19433702     DOI: 10.1001/archinternmed.2009.71

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  210 in total

1.  Prescribing by pharmacists: information paper (2009).

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-05

2.  Optimizing pharmacotherapy in older patients: a European perspective.

Authors:  Denis O'Mahony; Antonio Cherubini; Mirko Petrovic
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

3.  Introduction of pharmaceutical expertise in a palliative care team in Sweden.

Authors:  Barbro Norrström; Ing-Britt Cannerfelt; Helen Frid; Kim Roos; Helena Ramström
Journal:  Pharm World Sci       Date:  2010-10-30

Review 4.  The role of the pharmacist in optimizing pharmacotherapy in older people.

Authors:  Anne Spinewine; Daniela Fialová; Stephen Byrne
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 5.  Adverse drug reactions in older people: detection and prevention.

Authors:  Mirko Petrovic; Tischa van der Cammen; Graziano Onder
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

6.  Risk of prescribing errors in acutely admitted patients: a pilot study.

Authors:  Dorthe Krogsgaard Bonnerup; Marianne Lisby; Eva Aggerholm Sædder; Charlotte Arp Sørensen; Birgitte Brock; Ljubica Andersen; Anette Gjetrup Eskildsen; Lars Peter Nielsen
Journal:  Int J Clin Pharm       Date:  2016-07-09

7.  Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study.

Authors:  Henk Frans Kwint; Adrianne Faber; Jacobijn Gussekloo; Marcel L Bouvy
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

8.  Quality indicators for in-hospital pharmaceutical care of Dutch elderly patients: development and validation of an ACOVE-based quality indicator set.

Authors:  Peter C Wierenga; Joanna E Klopotowska; Susanne M Smorenburg; Hendrikus J van Kan; Yuma A Bijleveld; Marcel G Dijkgraaf; Sophia E de Rooij
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

9.  Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use.

Authors:  Amna Al-Hashar; Ibrahim Al-Zakwani; Tommy Eriksson; Alaa Sarakbi; Badriya Al-Zadjali; Saif Al Mubaihsi; Mohammed Al Za'abi
Journal:  Int J Clin Pharm       Date:  2018-05-12

Review 10.  The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review.

Authors:  Henk-Frans Kwint; Lynette Bermingham; Adrianne Faber; Jacobijn Gussekloo; Marcel L Bouvy
Journal:  Drugs Aging       Date:  2013-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.